Difference between synthroid and levothyroxine
Pro Research Analysisby 
Searched over 200M research papers
Differences Between Synthroid and Levothyroxine
Introduction to Synthroid and Levothyroxine
Synthroid and levothyroxine are both medications used to treat hypothyroidism, a condition where the thyroid gland does not produce enough thyroid hormone. While Synthroid is a brand-name drug, levothyroxine is the generic form. Despite their similar purposes, there are notable differences in their bioavailability, clinical outcomes, and patient responses.
Bioavailability and Absorption Rates
Synthroid vs. Generic Levothyroxine
Studies have shown that there are significant differences in the bioavailability and absorption rates between Synthroid and generic levothyroxine formulations. For instance, a study comparing Synthroid and Levoxine (another brand of levothyroxine) found statistically significant differences in the rate and extent of absorption. The area under the curve (AUC) and maximum peak plasma concentration (Cmax) were higher for Levoxine compared to Synthroid, indicating that these two formulations are not bioequivalent and can result in different serum T4 concentrations .
Clinical Interchangeability
Despite differences in bioavailability, some studies suggest that Synthroid and certain generic levothyroxine formulations are clinically interchangeable. For example, a study evaluating the interchangeability of Synthroid and Levoxine found no significant differences in clinical scores of hypothyroidism and hyperthyroidism, free thyroxine index (FTI), or thyroid-stimulating hormone (TSH) levels after switching between the two brands . Another study concluded that the differences in bioavailability between Levothroid and Synthroid were clinically unimportant, suggesting therapeutic interchangeability .
Clinical Outcomes and TSH Variance
Control of Hypothyroidism
In a study focusing on children with congenital hypothyroidism, generic levothyroxine was found to result in similar or better control of hypothyroidism compared to Synthroid. The study measured TSH variance and the frequency of levothyroxine dose adjustments, finding no significant differences between the two groups .
Severe Hypothyroidism in Children
However, another study indicated that Synthroid and an AB-rated generic levothyroxine are not bioequivalent for children with severe congenital hypothyroidism. The study found that the serum TSH concentration was significantly lower after 8 weeks of Synthroid compared to the generic drug, suggesting that Synthroid may be more effective in maintaining appropriate TSH levels in these patients .
Long-term Clinical Outcomes
Switching Formulations
A large retrospective study examined the clinical outcomes of patients who switched from Synthroid to an alternative levothyroxine formulation. The study found that switchers were more likely to have out-of-range TSH levels and adverse clinical outcomes such as chronic kidney disease, depression, fatigue, hypertension, and obesity compared to continuous users of Synthroid. This supports clinical guidelines recommending consistent use of a single levothyroxine formulation to avoid negative clinical outcomes .
Physicochemical Properties
Tablet Composition
The physicochemical properties of different levothyroxine brands, including weight variation, thickness, hardness, and disintegration time, have been evaluated. These properties showed slight differences within the acceptable range, indicating that while there are minor variations, they generally meet the required standards .
Conclusion
In summary, while Synthroid and generic levothyroxine are both used to treat hypothyroidism, they differ in bioavailability, absorption rates, and clinical outcomes. Synthroid may offer more consistent TSH control in certain populations, such as children with severe congenital hypothyroidism. However, for many patients, generic levothyroxine can be an effective and interchangeable option. Consistent use of a single formulation is recommended to maintain stable thyroid hormone levels and avoid adverse clinical outcomes.
Sources and full results
Most relevant research papers on this topic